-
ACLA Urges FDA To Adopt Greater Flexibility Predetermined Change Control Plans (PCCPs)
-
ACLA Comments on CY 2025 PFS Proposed Rule
-
ACLA Response to Cures 2.0 RFI
-
ACLA Statement to Ways & Means Committee on Innovation Field Hearing
-
ACLA Weighs in on American Privacy Rights Act (APRA)
-
ACLA Challenge to FDA’s Final Rule Regulating Laboratory Developed Testing Services as Medical Devices
-
ACLA Response to CMS RFI on Medicare Advantage Data
-
Toolkit: Medical Laboratory Professionals Week
-
Toolkit: SALSA Day of Action
-
ACLA Responds to Sen. Cassidy RFI on Diagnostic Regulation
